Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 395-404

  Wasowska, Barbara ^a,b   Wieder, Kenneth J ^a   Hancock, Wayne W ^a,c   Zheng, Xin Xiao ^a   Berse, Brygida ^a   Binder, Jochen ^b,d   Strom, Terry B ^a   Kupiec Weglinski, Jerzy W ^b,e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ALFRED HOSPITAL   (Australia)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CYTOKINE; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BASE SEQUENCE; CYTOKINES; DOWN-REGULATION; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; ISOANTIBODIES; MALE; MOLECULAR SEQUENCE DATA; POLYENES; RATS; RATS, INBRED BN; RATS, INBRED LEW; SIROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 0030027421     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Morris, R. E 1992 Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant. Rev. 6:39.
2. Sigal, N. H., and F J Dumont 1992 Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519
3. Morris, R. E., and B M. Meiser 1989 Identification of a new pharmacologic action for an old compound. Med Sci. Res 17:877.
4. Calne, R. Y., D S Collier, S. Lim, S. G. Pollard, A. Samaan, D. J. White, and S. Thiru. 1989. Rapamycin for immunosuppression in organ allografting. Lancet 2:227
5. Stepkowski, S M., H. Chen, P. Daloze, and B. D. Kahan. 1991 Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney and small bowel transplantation in the rat. Transplantation 51:22.
6. Morris, R., J. Wang, and C. Gregory. 1991. Initial studies of the efficacy and safety of rapamycin (RPM) administered to cynomolgus monkey recipients of heart allografts. J. Heart Lung Transplant 10:182.
7. Morris, R. E , B. M. Meiser, J Wu, R. Shorthouse, and J. Wang. 1991. Use of rapamycin for the suppression of alloimmune reactions m vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions. Transplant. Proc 23:521
8. Chen, H. J., J. P. Wu, H. Y. Luo, and P. M Daloze. 1991. Reversal of ongoing rejection of allografts by rapamycin. Transplant. Proc. 23:2241.
9. Gregory, C R , P. Huie, M. E Billingham, and R. E. Morris. 1993. Rapamycin inhibits arterial intimai thickening caused by both alloimmune and mechanical injury. Transplantation 55:1409.
10. Di Stefano, R., J. W, Kupiec-Weglinski, L. C. Uhteg, J. Puskas, D. Araneda. T. Diamantstein, and N L. Tilney 1988. Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18 Transplant. Proc. 20(Suppl. 2):217.
11. Hancock, W. W., R Di Stefano, P Braun, R Schweizer, N. L Tilney, and J. W. Kupiec-Weglinski 1990. CsA and anti-interleukin 2-receptor monoclonal antibody therapy in rats suppress accelerated rejection of cardiac allografts through different effector mechanisms. Transplantation 48:416
12. Kupiec-Weglinski, J. W., B. Wasowska, I. Papp, G Schmidbauer, M. H. Sayegh, W M. Baldwin III, K. J. Wieder, and W W Hancock. 1993 CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J. Immunol. 151:5053.
13. Sablinski, T., M. H Sayegh, W. W. Hancock, P Kut, C. A. Kwok, E. L. Milford, N. L. Tilney, and J. W. Kupiec-Weglinski 1991. Differential role of CD4+ cells m the sensitization and effector phases of accelerated graft rejection. Transplantation 51:226.
14. Wieder, K. J , W. W Hancock, G. Schmidbauer, C. L Corpier, I Wieder, L. Kobzik, T. B. Strom, and J. W. Kupiec-Weglinski 1993. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, arid IFN-γ in rat recipients of cardiac allografts. J. Immunol 151:1158.
15. Schmidbauer, G., W. W Hancock, B. Wasowska, A. M. Badger, and J. W. Kupiec-Weglinski. 1994. Rapamycin abrogates accelerated rejection in sensitized rats by inhibiting alloantibody responses and selectively suppressing intragraft mononuclear and endothelial cell activation, cytokine production and cell adhesion. Transplantation 57:933.
16. Halloran, P., and N Goes. 1993 Interferon-γ and its receptor Transplant. Sci. 3:92
17. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist Proc. Natl. Acad Sci. USA 90:3725.
18. Trinchieri, G. 1993 Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 14:335
19. Chan, S. H , B Perussia, J W Gupta, M. Kobayashi, M Pospisil, H. A. Young, S F. Wolf, D Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon-γ production by natural killer cells stimulatory factor: characterization of responder cells and synergy with other inducers J Exp. Med 173:869.
20. Chan, S , M. Kobayashi, D. Santoli, B. Perussia, and G Trinchieri. 1992 Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). J Immunol 148:92.
21. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer stimulatory factor/IL-12 synthesis in accessory cells J. Exp. Med 178:1041.
22. D'Andrea, A , M Rengaraju, N M. Valiante, J Chehimi, M Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
23. Mattner, F., S. Fischer, S. Guckes, S. Jin, H Kaulen, E. Schmidt, E Rude, and T. Germann. 1993 The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer Eur. J. Immunol. 23:2202
24. Morris, S. C., K. B. Madden, J J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gatley, and F D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.
25. + T cells in vivo: differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol. 148:1308
26. Chirgwin, J M , A E. Przybyla, R I. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
27. Dallman, M. J., O. Shiho, T. H Page, K. J. Wood, and P J. Morris. 1991. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med. 173:79.
28. McKnight, A. J., D. W Mason, and A. N. Barclay. 1989. Sequence of rat interleukin 2 and analogous binding of a mouse cDNA probe to rat MHC class II associated invariant chain mRNA. Immunogenetics 30:145.
29. McKnight, A J., A. N. Barclay, and D W. Mason 1991 Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells J. Immunol 21:1187.
30. Goodmann, R E , J. Oblak, and R. G. Bell. 1992. Synthesis and characterization of rat interleukin-10 (IL-10) c DNA clones from the RNA of cultured OX8-OX22-thoracic duct T cells. Biochem. Biophys. Res. Commun 189:1
31. Platzer, C., G. Richter, K. Uberla, W. Muller, H. Blocker, T. Diamantstein, and T. Blankenstein. 1992. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 22:1179.
32. Zheng, X. X., T. B. Strom, and A W. Steele. 1994. Quantitative comparison of rapamycin and cyclosporine effects on cytokine gene expression studied by reverse transcriptase-competitive polymerase chain reaction Transplantation 58:87.
33. Wasowska, B , W M. Baldwin, D N. Howell, and R Sanfilippo. 1993. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses. Transplantation 56:672.
34. Lee, J J , and N. A Costlow 1987. A molecular titration assay to measure transcript prevalence levels Methods Enzymol. 152:633.
35. Calvo, V , C M Crews, T A. Vik, and B E. Bierer 1992 Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad Sci. USA 89:7571.
36. Dumont, F J., M. J. Staruch, S. L Koprak, M. R Melino, and N. H. Sigal 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin, J. Immunol. 144:251.
37. Miyazaki, T , Z J Liu, A Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E L. Barsoumian, R. M. Perlmutter, and T. Taniguchi. 1995. Three distinct IL-2 signalling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81:223.
38. Taniguchi, T. 1995 Cytokine signalling through nonreceptor protein tyrosine kinases Science 268 251.
39. Manetti, R., P Parronchi, M G. Giudizi, M P Piccinni, E Maggi, G. Trinchieri, and S. Romagnani. 1993 Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp Med. 177:1199.
40. McKnight, A. J , G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K Abbas. 1994. Effects of IL-12 on helper T cell dependent immune responses in vivo. J. Immunol 152:2172
41. Sypek, J. P., C. L. Chung, S. E H Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S F Wolf, and R. G Schaub 1993. Resolution of cutaneous Leishmaniasis, interleukin 12 initiates a protective T helper type I immune response. J Exp. Med 177:1797.
42. Ling, P., M. K. Gatley, U Gubler, A. S. Stern, P. Lin, K. Hollfelder, C. Su, Y. E. Pan, and J Hakimi 1995. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity- J. Immunol. 154:116
43. Nadeau, K. C., H. Azuma, and N L. Tilney. 1995. Sequential cytokine dynamics in chronic rejection of rat renal allografts roles for cytokines RANTES and MCP-1 Proc. Natl Acad Sci. USA 92:8729.
44. Kennedy, M. K., K S. Pich, K. D Shanebeck, D M. Anderson, and K H. Grabstein 1994. Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0. clones. Eur. J. Immunol 24:2271.
45. Gazzinelli, R T , S Hieny, T. A Wynn, S Wolf, and A Sher. 1993. Interleukin 12 is required for the T-lymphocyte-dependent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts Proc Natl. Acad. Sci. USA 90:6115.
46. Manetti, R., F. Gerosa, M. G Giudizi, R Biagotti, P. Parronchi, M P. Piccini, S Sampognaro, E. Maggi, S. Romagnani, and G. Trinchieri 1994. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 clones. J. Exp Med 179:1273
47. Wasowska, B., K J. Wieder, W. W Hancock, B Berse, J. Binder, T. B. Strom, and J W Kupiec-Weglinski. 1995 Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. Transplant. Proc. 27:423
48. Lowry, R P. 1993. The relationship of IL-4, IL-10 and other cytokines to transplantation tolerance. Transplant. Sci. 3:104.
49. Nickerson, P., W. Steurer, J. Steiger, X. Zheng, A. W. Steele, and T. B. Strom. 1994. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6:757.
50. Ferraresso, M , L. Tian, R. Ghobrial, S. M. Stepkowski, and B. D. Kahan. 1994. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J. Immunol 153:3307.
51. Katsiskis, P. D., C. Q. Chu, F. M. Brennan, R. N. Maini, and M. Feldmann. 1994 Immunoregulatory role of interleukin 10 in rheumatoid arthritis J. Exp. Med. 179:1517.
52. Lee, M. L , L Wogensen, J. Shizuru, M. B. A. Oldstone, and N Sarvetnick. 1994. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93:1332.
53. Zheng, X., A. W. Steele, P. W. Nickerson, W. Steurer, J. Steiger, and T. B Strom. 1995 Administration of non-cytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation J. Immunol 154:5590.
54. Hughes-Jones, N. C., B. D. Gorick, and J. C. Howard. 1983. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies. Eur. J. Immunol. 13:635.
55. Fust, G., G. A. Medgyesi, H. Bazin, and J. Gergely. 1980. Differences in the ability of rat IgG subclasses to consume complement in homologous and heterologous serum. Immunol. Lett. 1:249.
56. Germann, T., M. Bongartz, H Dlugonoska, H Hess, E. Schmitt, L. Kolbe, E. Kolsch, F. J. Podlaski, M K Gatley, and E. Rude. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclass in vivo. Eur. J. Immunol. 25:823
57. Chassoux, D. M., L. G. Linares-Cruiz, H Bazin, and M. Stanislawski. 1988. K-cell mediated cytotoxicity induced with rat monoclonal antibodies. I Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors. Immunology 65:623.